In addition to Bid, which we identified as a crucial mediator of cisplatin/LA-12- and TRAIL-induced apoptosis in prostate cancer cells, we examined the potential changes in the level of other BH3 only Bcl-2 family members. Here, BCL2 is linked to prostate carcinoma.